Seegene Accelerates US Business with Successive Hiring of Local Experts...

Glenn Hanson, Head of Medical Science Division, Seegene USA Corporation

[Asia Economy Reporter Chunhee Lee] Seegene has recruited Dr. Glen Hanson, a bio-clinical expert, as the head of the medical science division at its U.S. subsidiary. Following the recent appointment of molecular diagnostics expert Dr. Richard Krieger as the head of the U.S. subsidiary last month, the company is accelerating its U.S. business by continuously bringing in local experts.

Seegene announced on the 17th that it has appointed Dr. Glen Hanson as the head of the medical science division at its U.S. subsidiary. Dr. Hanson majored in microbiology and immunology at the University of Saskatchewan in Canada and earned a Ph.D. in clinical microbiology from the same university's graduate school. He is an expert in molecular diagnostics and bio-clinical fields and has recently worked as the molecular diagnostics lab director at Hennepin County Medical Center in Minnesota, USA.

Based on decades of laboratory experience and an extensive network, Dr. Hanson plans to launch an advisory group composed of experts in the medical and scientific fields and accelerate the commercialization of products based on clinical utility. Additionally, he will provide solutions tailored to the U.S. market for FDA approvals and clinical trials of Seegene’s existing product lineup, supporting the company’s entry into the U.S. market.

Richard Krieger, head of Seegene’s U.S. subsidiary, stated, "Dr. Hanson will ensure the commercialization of Seegene’s diverse products within the U.S., and will strengthen strategic partnerships with the U.S. medical community as well as research institutions. We expect him to support Seegene’s full-scale U.S. business."

Dr. Hanson also said, "I am pleased to join Seegene during this period of growth and transformation. I will work to lead Seegene’s changes and contribute to improving patient health by expanding the product portfolio not only in COVID-19 but also in various non-COVID areas."

This content was produced with the assistance of AI translation services.